NCT04645797 2025-08-06
A Dose Escalation Study of APR003 in Patients With Advanced Colorectal Cancer (CRC) With Malignant Liver Lesions
Apros Therapeutics, Inc
Phase 1 Terminated
Clinical Trials
6 trialsNCT06521866 2025-03-14
Phase II Study of Serplulimab Combined with First-Line Targeted Therapy, Chemotherapy, and Radiation in Advanced Colorectal Cancer
Fudan University
Phase 2 Recruiting
NCT05894694 2024-12-27
Survival Benefit of Compound Kushen Injection in the Treatment of Advanced Colorectal Cancer
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Phase 4 Recruiting
NCT05406206 2022-06-06
Hepatic Arterial Infusion Chemotherapy With Fruquintinib for Colorectal Cancer Liver Metastases As Third-line Therapy
Peking University Cancer Hospital & Institute
Phase 2 Unknown
NCT04582981 2021-10-26
Fruquintinib and Raltitrexed Versus Fruquintinib Monotherapy in Advanced Colorectal Cancer
Fudan University
Phase 2 Unknown
NCT04771715 2021-02-25
Regorafenib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Patients With Advanced Colorectal Cancer
Peking Union Medical College Hospital
Unknown